Chronic Myeloid Leukemia, Version 2.2021

被引:189
作者
Deininger, Michael W. [1 ]
Shah, Neil P. [2 ]
Altman, Jessica K. [3 ]
Berman, Ellin [4 ]
Bhatia, Ravi [5 ]
Bhatnagar, Bhavana [6 ,7 ]
DeAngelo, Daniel J. [8 ]
Gotlib, Jason [9 ]
Hobbs, Gabriela [10 ]
Maness, Lori [11 ]
Mead, Monica [12 ]
Metheny, Leland [13 ,14 ]
Mohan, Sanjay [15 ]
Moore, Joseph O. [16 ]
Naqvi, Kiran [17 ]
Oehler, Vivian [18 ]
Pallera, Arnel M. [19 ]
Patnaik, Mrinal [20 ]
Pratz, Keith [21 ]
Pusic, Iskra [22 ,23 ]
Rose, Michal G. [24 ]
Smith, B. Douglas [25 ]
Snyder, David S. [26 ]
Sweet, Kendra L. [27 ]
Talpaz, Moshe [28 ]
Thompson, James [29 ]
Yang, David T. [30 ]
Gregory, Kristina M. [31 ]
Sundar, Hema [31 ]
机构
[1] Univ Utah, Huntsman Canc Inst, Salt Lake City, UT 84112 USA
[2] UCSF Helen Diller Family Comprehens Canc Ctr, San Francisco, CA USA
[3] Northwestern Univ, Robert H Lurie Comprehens Canc Ctr, Evanston, IL 60208 USA
[4] Mem Sloan Kettering Canc Ctr, 1275 York Ave, New York, NY 10021 USA
[5] UAB, ONeal Comprehens Canc Ctr, Birmingham, AL USA
[6] Ohio State Univ, James Canc Hosp, Comprehens Canc Ctr, Columbus, OH 43210 USA
[7] Solove Res Inst, Columbus, OH USA
[8] Dana Farber Brigham & Womens Canc Ctr, Boston, MA USA
[9] Stanford Canc Inst, Stanford, CA USA
[10] Massachusetts Gen Hosp, Canc Ctr, Boston, MA 02114 USA
[11] Fred & Pamela Buffett Canc Ctr, Omaha, NE USA
[12] UCLA Jonsson Comprehens Canc Ctr, Los Angeles, CA USA
[13] Univ Hosp Seidman Canc Ctr, Case Comprehens Canc Ctr, Cleveland, OH USA
[14] Cleveland Clin, Taussig Canc Inst, Cleveland, OH 44106 USA
[15] Vanderbilt Ingram Canc Ctr, Nashville, TN USA
[16] Duke Canc Inst, Durham, NC USA
[17] Univ Texas MD Anderson Canc Ctr, 1515 Holcombe Blvd, Houston, TX 77030 USA
[18] Fred Hutchinson Canc Res Ctr, Div Basic Sci, 1124 Columbia St, Seattle, WA 98104 USA
[19] Univ Tennessee, Hlth Sci Ctr, St Jude Childrens Res Hosp, Knoxville, TN 37996 USA
[20] Mayo Clin, Canc Ctr, Rochester, MN USA
[21] Univ Penn, Abramson Canc Ctr, Philadelphia, PA 19104 USA
[22] Barnes Jewish Hosp, Siteman Canc Ctr, St Louis, MO 63110 USA
[23] Washington Univ, Sch Med, St Louis, MO USA
[24] Smilow Canc Hosp, Yale Canc Ctr, New Haven, CT USA
[25] Johns Hopkins, Sidney Kimmel Comprehens Canc Ctr, Baltimore, MD USA
[26] City Hope Natl Med Ctr, 1500 E Duarte Rd, Duarte, CA 91010 USA
[27] H Lee Moffitt Canc Ctr & Res Inst, Tampa, FL USA
[28] Univ Michigan, Rogel Canc Ctr, Ann Arbor, MI 48109 USA
[29] Roswell Park Comprehens Canc Ctr, Buffalo, NY USA
[30] Univ Wisconsin, Carbone Canc Ctr, Madison, WI 53706 USA
[31] Natl Comprehens Canc Network, Plymouth Meeting, PA USA
来源
JOURNAL OF THE NATIONAL COMPREHENSIVE CANCER NETWORK | 2020年 / 18卷 / 10期
关键词
CHRONIC MYELOGENOUS LEUKEMIA; TYROSINE-KINASE INHIBITORS; CHRONIC-PHASE CML; CLONAL CHROMOSOMAL-ABNORMALITIES; IN-SITU HYBRIDIZATION; PHILADELPHIA-NEGATIVE CELLS; PATIENTS RECEIVING IMATINIB; STANDARD-DOSE IMATINIB; SUBCUTANEOUS OMACETAXINE MEPESUCCINATE; PULMONARY ARTERIAL-HYPERTENSION;
D O I
10.6004/jnccn.2020.0047
中图分类号
R73 [肿瘤学];
学科分类号
100214 ;
摘要
Chronic myeloid leukemia (CML) is defined by the presence of Philadelphia chromosome (Ph) which results from a reciprocal translocation between chromosomes 9 and 22 (t(9;22] that gives rise to a BCR-ABL1 fusion gene. CML occurs in 3 different phases (chronic, accelerated, and blast phase) and is usually diagnosed in the chronic phase. Tyrosine kinase inhibitor therapy is a highly effective first-line treatment option for all patients with newly diagnosed chronic phase CML. This manuscript discusses the recommendations outlined in the NCCN Guidelines for the diagnosis and management of patients with chronic phase CML.
引用
收藏
页码:1385 / 1415
页数:31
相关论文
共 273 条
[1]   Pregnancy Management in CML Patients: To Treat or Not to Treat? Report of 224 Outcomes of the European Leukemia Net (ELN) Database [J].
Abruzzese, Elisabetta ;
Turkina, Anna G. ;
Apperley, Jane F. ;
Bondanini, Francesco ;
de Fabritiis, Paolo ;
Kim, Dong-Wook ;
Dyagil, Iryna ;
Ganeva, Penka ;
Garcia-Gutierrez, Valentin ;
Kazakbaeva, Khamida ;
Klamova, Hana ;
Kotlyarchuk, Konstantin ;
Mauro, Michael J. ;
Milojkovic, Dragana ;
Moriaghi, Beatriz ;
Meliktesyan, Karen ;
Nicolini, Franck E. ;
Polushkina, Evgenia ;
Rea, Delphine ;
Rousselot, Philippe ;
Shacham, Adi ;
Shmakov, Roman ;
Trawinska, Malgorzata Monika ;
Chelysheva, Ekaterina Yu. .
BLOOD, 2019, 134
[2]   Tyrosine Kinase Inhibitors and Pregnancy [J].
Abruzzese, Elisabetta ;
Trawinska, Malgorzata Monika ;
Perrotti, Alessio Pio ;
De Fabritiis, Paolo .
MEDITERRANEAN JOURNAL OF HEMATOLOGY AND INFECTIOUS DISEASES, 2014, 6 (01)
[3]   Progressive peripheral arterial occlusive disease and other vascular events during nilotinib therapy in CML [J].
Aichberger, Karl J. ;
Herndlhofer, Susanne ;
Schernthaner, Gerit-Holger ;
Schillinger, Martin ;
Mitterbauer-Hohendanner, Gerlinde ;
Sillaber, Christian ;
Valent, Peter .
AMERICAN JOURNAL OF HEMATOLOGY, 2011, 86 (07) :533-539
[4]   Correlations Between Cytogenetic and Molecular Monitoring Among Patients With Newly Diagnosed Chronic Myeloid Leukemia in Chronic Phase Post Hoc Analyses of the Rationale and Insight for Gleevec High-Dose Therapy Study [J].
Akard, Luke P. ;
Cortes, Jorge E. ;
Albitar, Maher ;
Goldberg, Stuart L. ;
Warsi, Ghulam ;
Wetzler, Meir ;
Ericson, Solveig G. ;
Radich, Jerald P. .
ARCHIVES OF PATHOLOGY & LABORATORY MEDICINE, 2014, 138 (09) :1186-1192
[5]   Pregnancy in chronic myeloid leukemia patients treated with alpha interferon [J].
Al Bahar, S ;
Pandita, R ;
Nath, SV .
INTERNATIONAL JOURNAL OF GYNECOLOGY & OBSTETRICS, 2004, 85 (03) :281-282
[6]  
Aleem Aamer, 2009, Hematol Oncol Stem Cell Ther, V2, P358
[7]   Prognostic significance of additional chromosomal abnormalities at the time of diagnosis in patients with chronic myeloid leukemia treated with frontline tyrosine kinase inhibitors [J].
Alhuraiji, Ahmad ;
Kantarjian, Hagop ;
Boddu, Prajwal ;
Ravandi, Farhad ;
Borthakur, Gautam ;
DiNardo, Courtney ;
Daver, Naval ;
Kadia, Tapan ;
Pemmaraju, Naveen ;
Pierce, Sherry ;
Garcia-Manero, Guillermo ;
Wierda, William ;
Verstovsek, Srdan ;
Jabbour, Elias ;
Cortes, Jorge .
AMERICAN JOURNAL OF HEMATOLOGY, 2018, 93 (01) :84-90
[8]   Successful pregnancy and delivery in a patient with chronic myelogenous leukemia (CML), and management of CML with leukapheresis during pregancy:: a case report and review of the literature [J].
Ali, R ;
Özkalemkas, F ;
Özkocaman, V ;
Özçelik, W ;
Ozan, U ;
Kimya, Y ;
Tunali, A .
JAPANESE JOURNAL OF CLINICAL ONCOLOGY, 2004, 34 (04) :215-217
[9]   Imatinib use during pregnancy and breast feeding: a case report and review of the literature [J].
Ali, Ridvan ;
Ozkalemkas, Fahir ;
Kimya, Yalcin ;
Koksal, Nilgun ;
Ozkocaman, Vildan ;
Gulten, Tuna ;
Yorulmaz, Hakan ;
Tunali, Ahmet .
ARCHIVES OF GYNECOLOGY AND OBSTETRICS, 2009, 280 (02) :169-175
[10]   Outcome of pregnancy in chronic myeloid leukaemia patients treated with tyrosine kinase inhibitors: Short report from a single centre [J].
Alizadeh, H. ;
Jaafar, H. ;
Rajnics, P. ;
Khan, M. I. ;
Kajtar, B. .
LEUKEMIA RESEARCH, 2015, 39 (01) :47-51